助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   抗心力衰竭 的翻译结果: 查询用时:0.013秒
图标索引 在分类学科中查询
所有学科
更多类别查询

图标索引 历史查询
 

抗心力衰竭
相关语句
  anti-heart failure
     A new anti-heart failure drug: calcium sensitization
     新型抗心力衰竭药物钙离子敏感药
短句来源
     Methods:123 patients of DCM with heart failure were randomly divided into 3 groups (goup A,B,C). On the basis of regular anti-heart failure therapy,each group them was treated with thyroxine 20mg/d(group A),40mg/d(group B),or 60mg/d(group C) respectively for 4 week.
     方法 :12 3例 DCM心力衰竭患者随机分为 A、 B、 C三组 ,在常规抗心力衰竭治疗基础上分别加服甲状腺激素 2 0 mg/ d、 40 m g/ d、 6 0 mg/ d,疗程 4周 ;
短句来源
     Observation and nursing of adverse effects of familiar anti-heart failure medicine
     常见抗心力衰竭药物副反应的观察与护理
短句来源
     Calcium sensitizer——levosimendan(LS) is a new type anti-heart failure drug that exerts without increasing intracellular cAMP or Ca 2+ at therapeutic doses. Therefore it may avoid major limitations of above positive inotropic drugs. In addtition,it has a vasodilator action due to an opening of the ATP-sensitive potassium channels.
     钙增敏剂———Levosimendan是不增加细胞内环磷酸腺和Ca2+的新型抗心力衰竭药物,避免了上述药物的不利作用,并且因为激活ATP敏感型钾通道而有扩血管作用。
短句来源
  “抗心力衰竭”译为未确定词的双语例句
     ②The P-selectin, plasma von Willebrand's disease and D-dimer level decreased in the standard CHF group as compared with that before treatment (18.02±2.65),(21.45±3.97) g/L;
     ②标准抗心力衰竭组治疗后P-选择素、血管性假性血友病因子和D-二聚体水平较治疗前均下降眼(18.02±2.65),(21.45±3.97)g/L;
短句来源
     ②The levels of ET 1 were obviously reduced after comprehensive drug treatment of anti CHF(t=3.574,P< 0.01).
     ②经抗心力衰竭药物综合治疗后,ET-1水平降低(t=3.574,P<0.01)。
短句来源
     METHODS: A total of 60 patients with CHF (cardiac function of Ⅱ-Ⅳ grade), who were treated at the First Affiliated Hospital of Anhui Medical University from January 2004 to July 2005, were selected and randomly assigned into standard anti-CHF group with 30 cases and aspirin group with 30 cases.
     方法:选择2004-01/2005-07安徽医科大学第一附属医院收治的60例慢性心力衰竭患者(心功能Ⅱ~Ⅳ级),随机分为标准抗心力衰竭组30例及阿司匹林组30例。
短句来源
     Standard anti-CHF therapy was performed in the standard anti-CHF group, including single angiotensin-converting enzyme inhibitor agent or adding diuretic, combing cedoxin 0.125-0.25 mg per day, adding beta-receptor blocker in patients with Ⅱ-Ⅲ cardiac function.
     标准抗心力衰竭组接受标准抗心衰治疗,包括血管紧张素转化酶抑制剂单用或加用利尿剂,合用地高辛0.125~0.25mg/d,心功能Ⅱ~Ⅲ级患者加用β-受体阻滞剂;
短句来源
     2.The levels of plasma NE,E and ANP in 35 patients with CHF before treatment were significantly higher than after treatment(Pa<0.01).
     2.CHF组治疗前显著高于抗心力衰竭综合治疗心力衰竭好转后血浆NE、E、ANP水平,二组比较差异有显著性(Pa<0.01)。
短句来源
更多       
  相似匹配句对
     Intervention with anti-H.
     H.
短句来源
     Anti-H.
     H .
短句来源
     Management Strategies of Arrhythmia Associated with Heart Failure
     心力衰竭心律失常治疗
短句来源
     Advances of Research on Pharmacotherapy of Congestive Heart Failure
     慢性心力衰竭药物研究进展
短句来源
     Inflammation and Heart Failure
     炎症和心力衰竭
短句来源
查询“抗心力衰竭”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
没有找到相关例句


It was reported that Astragatoside Ⅲ,Ⅳ,and Ⅵ isolated from Chinese medicine Huanqi (Astragalus membranceus (Fisch) Bunge),and Superoxide anion free radical scaverging activity of theese constituents was detected by Chemilumineseenee and Chemiluminescent system of Lumi- nol-Xanthine-Xanthine Oxidase.Its O(?)scaverging activity was quantitated by medicine concentration (LC_(50)) which inhibits 50% Chemiluminescent intensity.The LC_(50) of Astragaloside Ⅲ,Ⅳ and Ⅵ are 80,50,and 11μg/ml respeetively.Their structures...

It was reported that Astragatoside Ⅲ,Ⅳ,and Ⅵ isolated from Chinese medicine Huanqi (Astragalus membranceus (Fisch) Bunge),and Superoxide anion free radical scaverging activity of theese constituents was detected by Chemilumineseenee and Chemiluminescent system of Lumi- nol-Xanthine-Xanthine Oxidase.Its O(?)scaverging activity was quantitated by medicine concentration (LC_(50)) which inhibits 50% Chemiluminescent intensity.The LC_(50) of Astragaloside Ⅲ,Ⅳ and Ⅵ are 80,50,and 11μg/ml respeetively.Their structures have been identified by analyses of their various spectra data and comfirmed by comparison with IR spectra of authentic samples.It may be concluded that the Astragalosides from Huanqi is the active principle possessed an O(?)seaverging activity.

本文使用黄嘌呤-黄嘌呤氧化酶-鲁米诺化学发光体系和化学发光检测法研究了黄芪中各成分的清除超氧阴离子自由基的能力,以药物抑制发光强度50%的浓度(LC_(50))为指标,经研究证明,黄芪总皂部分(N)具有较强的活性,LC_(50)为185μg/ml,再经进一步导向分离并鉴定证明,黄芪甙Ⅲ,Ⅳ和Ⅵ的 LC_(50)分别为80、50和11μg/ml。从而确证黄芪的抗心力衰竭的有效成分可能为黄芪甙的混合组成。

The effects of different

本实验用血流动力学方法,在戊巴比妥钠所致的实验性心力衰竭动物模型上,研究了不同剂量的黄芪皂甙对衰竭心脏的作用。通过与对照组对比观察发现,低剂量黄芪皂甙(2mg)可加重心衰,而中等剂量(4mg)和高剂量黄芪(8mg)有抗心力衰竭的作用

Abstract This paper reported the effect of metoprolol on congestive heart failure in 38 patients with fast heart rate and using cardiotonic diuretic and vasodilator therapy.The results showed that in patients taking metoprolol,plasma catecholamine(CA),epinephrine(E),norepinephrine(NE)decreased from 7.31±1.41 to 3.71±0.76nmol/L from 3.39±1.31 to 2.40±0.70nmol/L from 5.55±0.159 to 2.06±0.94nmol/L,respectively.Heart rate decreased from 108.84±14.78 to 69.54±8.72.Effective rate was 97.4%.There were few side-effects.These...

Abstract This paper reported the effect of metoprolol on congestive heart failure in 38 patients with fast heart rate and using cardiotonic diuretic and vasodilator therapy.The results showed that in patients taking metoprolol,plasma catecholamine(CA),epinephrine(E),norepinephrine(NE)decreased from 7.31±1.41 to 3.71±0.76nmol/L from 3.39±1.31 to 2.40±0.70nmol/L from 5.55±0.159 to 2.06±0.94nmol/L,respectively.Heart rate decreased from 108.84±14.78 to 69.54±8.72.Effective rate was 97.4%.There were few side-effects.These data suggest that in congestive heart failure patients with fast heart rate and by cardiotonic,diuretic,vasodilator therapy,metoprolol is effective and may be drug of choice for combined treatment.

对38例经强心、利尿、扩管治疗无改善且伴快速室率的慢性充血性心力衰竭(CHF)加用美托洛尔治疗,结果显示其血浆儿茶酚胺由7.31±1.41减至3.71±0.76nmol/L;肾上腺素由3.39±1.31减至2.40±0.70nmol/L,去甲肾上腺素由5.55±1.59减至2.06±0.94nmol/L,心率由108.84±14.78减至69.54±8.72次/分,心功能改善总有效率达97.4%,且副作用少。提示:凡常规治疗后效果不佳并伴有快心室率的CHF患者,美托洛尔可作为抗心力衰竭的联合治疗药物。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关抗心力衰竭的内容
在知识搜索中查有关抗心力衰竭的内容
在数字搜索中查有关抗心力衰竭的内容
在概念知识元中查有关抗心力衰竭的内容
在学术趋势中查有关抗心力衰竭的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社